...
首页> 外文期刊>Journal of orthopaedic research >Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes.
【24h】

Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes.

机译:单核细胞来源的可编程细胞(PCMO):外周血干细胞的来源,其产生产生II型胶原的软骨细胞。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The focus of this study was a new adult pluripotent cell derived from human peripheral blood monocytes identified as a "programmable cell of monocytic origin" (PCMO). In contrast to bone marrow-derived stem cells, these cells can be harvested from peripheral venous blood without aspiration of the bone marrow and have multilineage potential comparable to that of mesenchymal stem cells (MSC). The aim of this study was to evaluate the potential of PCMOs to differentiate into collagen type II-producing chondrocytes using various extrinsic cues (TGFbeta-1, IGF-1, BMP-2, and BMP-7). Collagen type I and II proteins were localized using immunohistochemistry and quantified by enzyme-linked immunosorbent assays (ELISA). The shape of the differentiating PCMOs was monitored with electron microscopy. Collagen type I and II messenger RNA expression was analyzed using real-time reverse transcriptase-polymerase chain reaction (RT PCR) and regular RT PCR. Immunohistochemistry revealed a strong accumulation of collagen type II after a 6-week incubation period with BMP-2, BMP-7, TGF-beta, IGF-I, and TGF-beta, and IGF-1. Collagen type I was only mildly induced by the applied stimulants. Electron microscopy findings showed a shift from a monocyte-like structure to a chondrocyte-like structure after 2 weeks of stimulation. Stimulation of PCMOs with BMP-2, BMP-7, TGF-beta, IGF-I, and TGF-beta, and IGF-1 induced a chondrogenic differentiation with continuous expression of collagen type II mRNA and protein over several weeks time. Collagen type I and II expression in undifferentiated PCMOs or in control cells incubated without any stimulant was not detected. PCMOs have the potential to differentiate into collagen type II synthesizing chondrocytes. The ability to reprogram and differentiate PCMOs from peripheral blood into sizable quantities might enable their clinical application in cartilage repair after mechanical injury or in cases of osteoarthritis.
机译:这项研究的重点是从人外周血单核细胞衍生的一种新的成年多能细胞,该细胞被鉴定为“单核细胞可编程细胞”(PCMO)。与骨髓来源的干细胞相反,这些细胞可从外周静脉血中采集而无需骨髓抽吸,并且具有与间充质干细胞(MSC)相当的多系潜在能力。这项研究的目的是评估PCMOs使用各种外部线索(TGFbeta-1,IGF-1,BMP-2和BMP-7)分化为产生II型胶原的软骨细胞的潜力。使用免疫组织化学对I型和II型胶原蛋白进行定位,并通过酶联免疫吸附测定(ELISA)进行定量。用电子显微镜监测分化的PCMO的形状。使用实时逆转录聚合酶链反应(RT PCR)和常规RT PCR分析I型和II型胶原蛋白信使RNA的表达。免疫组织化学显示,在与BMP-2,BMP-7,TGF-beta,IGF-I和TGF-beta和IGF-1孵育6周后,II型胶原蛋白大量积累。 I型胶原仅由所施加的刺激剂轻微诱导。电子显微镜检查结果显示,刺激2周后,从单核细胞样结构转变为软骨细胞样结构。用BMP-2,BMP-7,TGF-β,IGF-I和TGF-β以及IGF-1刺激PCMO可以诱导软骨分化,并在数周时间内连续表达II型胶原mRNA和蛋白质。未检测到未分化的PCMOs或未培养任何刺激物的对照细胞中的I型和II型胶原表达。 PCMO具有分化为II型胶原合成软骨细胞的潜力。重新编程并将PCMO从外周血中分化为大量的能力可能使其能够在机械损伤后或在骨关节炎的情况下用于软骨修复的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号